Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Herein, we successfully switched a patient with acromegaly from a DPP-4 inhibitor to a GLP-1 analog due to pasireotide-induced deterioration of glycemic control
Trefts E, Shaw RJ
This start low, go slow approach is essential because MCAS patients are notoriously sensitive to medications
Meanwhile, the company is gearing up for the launch of new manufacturing plants in North Carolina and Germany, which are slated to become operational by the end of the year and in 2027, respectively
US$ 23.21
US$ 25.47
US$ 20.28
US$ 27.17
